Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,520	5,878	15,403	10,379	5,459	8,215
Market Cap Growth	-50.12%	-61.84%	48.41%	90.12%	-33.55%	-8.90%
Enterprise Value	6,353	5,722	14,978	9,810	5,150	7,936
Last Close Price	207.00	186.60	489.00	329.50	183.00	278.50
PE Ratio	259.13	233.59	89.46	113.04	296.26	1007.78
Forward PE	61.61	51.19	92.61	199.34	111.93	211.39
PS Ratio	8.03	7.24	18.73	17.37	13.15	31.80
PB Ratio	3.09	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.45	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	64.52	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	7.82	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	45.88	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	71.89	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Net Debt / Equity Ratio	-0.08	-0.08	-0.18	-0.26	-0.16	-0.31
Net Debt / EBITDA Ratio	-1.21	-1.21	-3.44	-27.04	-17.78	33.59
Net Debt / FCF Ratio	-1.66	-1.66	-9.41	-157.29	-24.46	17.66
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.39%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.